Cookies show us what works. Privacy
Cookies show us what works. Privacy
28 funds hold it · Insiders net selling
Net selling: insiders sold $2.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Aug 5, 2026
Financial period
Q3 FY2026
Earnings per share
$0.09 expected
Revenue
Company release
Q4 FY2026 guidance
$760.0M to $780.0M
No comparable estimate
Estimates as of Nov 14, 2026
EPS expected
$0.12 to $0.19
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jun 27, 2026Reported Aug 5, 2026 | $0.09est. $0.09 | +$0.00in line | $720.8MCompany release | +21.7%from $592.1M |
| Mar 28, 2026Reported May 6, 2026 | $0.45est. $0.11 | +$0.34beat | $676.5MSEC filing | +23.1%from $549.7M |
| Dec 27, 2025Reported Feb 4, 2026 | $0.40est. $0.09 | +$0.31beat | $630.0MSEC filing | +29.4%from $486.7M |
| Sep 30, 2025Reported Nov 24, 2025 | $0.58est. $0.08 | +$0.50beat | $618.5MAlpha Vantage | +9.5%from $564.6M |
| Jun 28, 2025Reported Aug 6, 2025 | $0.07est. $0.05 | +$0.02beat | $592.1MSEC filing | +25.9%from $470.3M |
| Mar 29, 2025Reported May 7, 2025 | $0.05est. $0.05 | +$0.00in line | $549.7MSEC filing | +39.7%from $393.3M |
| Dec 28, 2024Reported Feb 5, 2025 | $0.32est. $0.03 | +$0.29beat | $486.7MSEC filing | +35.2%from $359.9M |
| Sep 28, 2024Reported Nov 18, 2024 | $0.47est. $0.06 | +$0.41beat | $564.6MSEC filing | +44.1%from $391.9M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $618.5M | $630.0M | $676.5M | $720.8M |
| Cost of what it sold | $491.3M | $496.6M | $526.5M | $559.9M |
| Gross profit | $127.1M | $133.4M | $150.0M | $160.9M |
| What it spent | ||||
| Research and development | $58.7M | $43.0M | $51.3M | $43.8M |
| Sales and admin | $83.6M | $81.2M | $92.6M | $84.2M |
| Total operating expenses | $142.4M | $124.2M | $143.8M | $128.0M |
| What was left | ||||
| Operating profit | -$15.3M | $9.2M | $6.1M | $32.9M |
| Profit before tax | -$19.6M | $14.0M | $10.0M | $53.9M |
| Tax | -$423.0K | $615.0K | $572.0K | -$1.1M |
| Net profit | -$3.6M | $2.6M | $2.0M | $11.7M |
| EBITDA | -$9.6M | $24.1M | $23.9M | $20.6M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bearish
After redeeming 2,000 units, director Charles Kane sold 2,000 Symbotic (SYM) shares under a trading plan.
Leans bearishNov 4A sale of 3,978 shares is planned by Symbotic (SYM) officer Miriam Ort.
NeutralOct 29Officer proposes selling 7,224 Symbotic (Nasdaq: SYM) shares acquired through stock vesting.
NeutralOct 28